The antitumor properties of synthetic heterocyclic compounds are among the most powerful properties that can be made use in medicinal chemistry. More specifically, their significant cytotoxic effects against many types of human tumor cells, as well as their roles as various kinase inhibitors. In recent years, Phthalazine derivatives, have frequently attracted the interest of medicinal chemistry researchers due to their promising anticancer properties. The present study is a review of the latest advances in Phthalazine derivative-related research, with a focus on their anticancer activities as VEGFR-2 inhibitors.
No takes yet. Share an insight, caveat, or question.
Dahab et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: